会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 72. 发明申请
    • IMAGE DISPLAY APPARATUS
    • 图像显示设备
    • US20090022411A1
    • 2009-01-22
    • US12175668
    • 2008-07-18
    • Masutaka INOUESusumu TanaseYoshinao HiranumaTakaaki AbeMasahiro Haraguchi
    • Masutaka INOUESusumu TanaseYoshinao HiranumaTakaaki AbeMasahiro Haraguchi
    • G06K9/46
    • H04N19/51
    • An image display apparatus 100 comprises: a low-luminance frame generator 230 configured to generate a low-luminance frame in which a luminance of an original frame corresponding to an image input signal is decreased; a motion-compensated frame generator 240 configured to generate a motion-compensated frame in which a motion of an object included in the original frame is compensated; a combining ratio changer 250 configured to change a combining ratio between the low-luminance frame and the motion-compensated frame according to an image characteristic obtained based on the image input signal; a combiner 260 configured to generate a combining frame by combining the low-luminance frame and the motion-compensated frame; and an output signal unit 270 configured to insert the combining frame between continuous original frames.
    • 图像显示装置100包括:低亮度帧发生器230,被配置为生成与图像输入信号对应的原始帧的亮度降低的低亮度帧; 被配置为生成运动补偿帧的运动补偿帧发生器240,其中补偿包括在原始帧中的对象的运动; 配置为根据基于图像输入信号获得的图像特性来改变低亮度帧和运动补偿帧之间的组合比的组合比率变换器250; 组合器260,被配置为通过组合低亮度帧和运动补偿帧来产生组合帧; 以及输出信号单元270,被配置为在连续的原始帧之间插入组合帧。
    • 77. 发明授权
    • Human renal disease marker substance
    • 人类肾脏疾病标志物质
    • US08709816B2
    • 2014-04-29
    • US13393091
    • 2010-09-03
    • Takaaki AbeTomoyoshi Soga
    • Takaaki AbeTomoyoshi Soga
    • G01N33/48G01N33/00
    • G01N33/6893G01N2800/347
    • The present invention relates to a method for diagnosing, and treating renal disease in a patient by having a test performed for detecting or quantifying one or more renal disease markers present in a test blood sample from the patient; and administering treatment to improve renal function. In particular embodiments, the test performed quantifies cis-aconitate, and the patient is identified as having the renal disease when a concentration of cis-aconitate present in the patient's test blood sample is higher than that of a control. Methods of the present invention can allow diagnosis and treatment of patients with early stage renal disease, such as early stage renal failure. Another aspect of the present invention relates to methods for screening for a prophylactic/therapeutic agent for treating renal disease using one or more renal disease markers.
    • 本发明涉及通过进行用于检测或定量来自患者的测试血液样品中存在的一种或多种肾脏疾病标志物的测试来诊断和治疗患者的肾脏疾病的方法; 并进行治疗以改善肾功能。 在具体实施方案中,进行的测试量化顺式乌头酸,并且当患者测试血液样品中存在的顺式乌头酸浓度高于对照组时,患者被鉴定为具有肾脏疾病。 本发明的方法可以允许诊断和治疗患有早期肾病的早期肾衰竭患者。 本发明的另一方面涉及使用一种或多种肾脏疾病标记物筛选用于治疗肾脏疾病的预防/治疗剂的方法。
    • 78. 发明申请
    • Novel Renal Disease Marker Substance in Human
    • 新型肾脏疾病标记物质
    • US20120193527A1
    • 2012-08-02
    • US13393091
    • 2010-09-03
    • Takaaki AbeTomoyoshi Soga
    • Takaaki AbeTomoyoshi Soga
    • H01J49/26
    • G01N33/6893G01N2800/347
    • An object of the present invention is to provide a method for accurately determining even a renal disease that could not have been detected by various conventional renal disease test methods with a reduced burden on a subject (a donor of a test sample). Another object of the present invention is to provide a method capable of determining an early stage renal disease, focusing on a renal disease marker substance with a small blind GFR area. Further, another object of the present invention is to provide a novel method for screening for a prophylactic/therapeutic agent for a renal disease capable of efficiently screening for a novel prophylactic/therapeutic agent for a renal disease that focused on a new, previously unnoticed renal disease marker substance. In order to achieve these objects, the present invention employs the step of detecting or quantifying one or two or more renal disease marker substances present in a test blood sample.
    • 本发明的一个目的是提供一种即使是通过各种常规肾脏疾病测试方法不能检测到的肾脏疾病的方法,其对受试者(受试样本的供体)的负担降低。 本发明的另一个目的是提供一种能够确定早期肾脏疾病的方法,其重点是具有小的GFR区域的肾脏疾病标记物质。 此外,本发明的另一个目的是提供一种筛选用于肾病的预防/治疗剂的新方法,其能够有效筛选用于肾脏疾病的新型预防/治疗剂,其集中在新的先前未被注意的肾脏 疾病标记物质。 为了实现这些目的,本发明采用检测或定量测试血液样品中存在的一种或两种以上肾脏疾病标记物质的步骤。